The effect of antiepileptic drugs on thyroid hormonal function: causes and implications

References

• Hauser WA. Incidence and prevalence. In: Engel J, Pedley TA, editors. Epilepsy: a comprehensive textbook. Lippincott-Raven; Philadelphia: 1997. p. 47-57
   Google Scholar
• Kandil MR, Ahmed WA, Sayed AM, Hamed SA. Pattern of epilepsy in childhood and adolescence: a hospital-based study. African J Neurol Scien 2007;26(1):33-45
   Google Scholar
• Engel JJr. Etiology as a risk factor for medically refractory epilepsy: A case for early surgical intervention. Neurology 1998;51(5):1243-4
   PubMed Web of Science ®Google Scholar
• Hamed SA. Leptin and insulin homeostasis in epilepsy: relation to weight adverse conditions. Epilepsy Res 2007;75(1):1-9
   PubMed Web of Science ®Google Scholar
• Hamed SA. Neuroendocrine hormonal conditions in epilepsy: relationship to reproductive and sexual functions. Neurologist 2008;14(3):157-69
   PubMed Web of Science ®Google Scholar
• Hamed SA. Antiepileptic drugs (AEDs) influences on weight in people with epilepsy. Expert Rev Clin Pharmacol 2014;8(1):103-14
   Google Scholar
• Calandre EP, Rodriquez-Lopez C, Blazquez A, Cano D. Serum lipids, lipoproteins and apolipoproteins A and B in epileptic patients treated with valproic acid, carbamazepine or phenobarbital. Acta Neurol Scand 1991;83(4):250-3
   PubMed Web of Science ®Google Scholar
• Nikolaos T, Stylianos G, Chryssoula N, et al. The effect of long-term antiepileptic treatment on serum cholesterol (TC, HDL, LDL) and triglyceride levels in adult epileptic patients on monotherapy. Med Sci Monit 2004;10(4):50-2
   Google Scholar
• Hamed SA, Hamed SA, Shokry M, et al. The reproductive conditions and lipid profile in females with epilepsy. Acta Neurol Scand 2007;115(1):12-27
   PubMed Web of Science ®Google Scholar
• Hamed SA, Hamed EA, Hamdy R, Nabeshima T. Vascular risk factors and oxidative stress as independent predictors of asymptomatic atherosclerosis in Adult patients with epilepsy. Epilepsy Res 2007;74(2-3):183-92
   PubMed Web of Science ®Google Scholar
• Hamed SA, Nabeshima T. The High Atherosclerotic Risk Among Epileptics: The Atheroprotective Role of Multivitamins. J Pharmacol Sci 2005;98(4):340-53
   PubMed Web of Science ®Google Scholar
• Hamed SA, Fida NM, Hamed EA. States of serum leptin and insulin in children with epilepsy: Risk predictors of weight gain. Eur J Paediatr Neurol 2009;13(3):261-8
   PubMed Web of Science ®Google Scholar
• Hamed SA, Abdellah MM, El-Melegy NT. Blood levels of trace elements, electrolytes and oxidative stress/antioxidant systems in epileptic patients. J Pharmacol Sci 2004;96(4):465-73
   PubMed Web of Science ®Google Scholar
• Hamed SA, Abdellah MM. Trace elements and electrolytes homeostasis and their relation to antioxidant enzyme activity in brain hyperexcitability of epileptic patients. J Pharmacol Sci 2004;96(4):349-59
   PubMed Web of Science ®Google Scholar
• Tanaka K, Kodama S, Yokoyama S, et al. Thyroid function in children with long-term anticonvulsant treatment. Pediatr Neurosci 1987;13(2):90-4
   PubMedGoogle Scholar
• Eiris-Punal J, Del Rio-Garma M, Del Rio-Garma MC, et al. Long-term treatment of children with epilepsy with valproate or carbamazepine may cause subclinical hypothyroidism. Epilepsia 1999;40(12):1761-6
   PubMed Web of Science ®Google Scholar
• Yılmaz U, Yılmaz TS, Akıncı G, et al. The effect of antiepileptic drugs on thyroid function in children. Seizure 2014;23(1):29-35
   PubMed Web of Science ®Google Scholar
• Deda G, Akinci A, Teziç T, Karagöl U. Effects of anticonvulsant drugs on thyroid hormones in epileptic children. Turk J Pediatr 1992;34(4):239-44
   PubMed Web of Science ®Google Scholar
• Isojärvi JI, Pakarinen AJ, Myllyla VV. Thyroid function with antiepileptic drugs. Epilepsia 1992;33(1):142-8
   PubMed Web of Science ®Google Scholar
• Lai EC, Yang YH, Lin SJ, Hsieh CY. Use of antiepileptic drugs and risk of hypothyroidism. Pharmacoepidemiol Drug Saf 2013;22(10):1071-9
   PubMed Web of Science ®Google Scholar
• Isojärvi JI, Pakarinen AJ, Myllyla VV. Thyroid function in epileptic patients treated with carbamazepine. Arch Neurol 1989;46(11):1175-8
   PubMed Web of Science ®Google Scholar
• Yüksel A, Kartal A, Cenani A, Yalçin E. Serum thyroid hormones and pituitary response to thyrotropin-releasing hormone in epileptic children receiving anti-epileptic medication. Acta Paediatr Jpn 1993;35(2):108-12
   PubMedGoogle Scholar
• Hamed SA, Hamed EA, Kandil MR, et al. Serum thyroid hormone balance and lipid profile in patients with epilepsy. Epilepsy Res 2005;66(1-3):173-83
   PubMed Web of Science ®Google Scholar
• Castro-Gago M, Novo-Rodríguez MI, Gómez-Lado C, et al. Evolution of subclinical hypothyroidism in children treated with antiepileptic drugs. Pediatr Neurol 2007;37(6):426-30
   PubMed Web of Science ®Google Scholar
• Aygün F, Ekici B, Aydinli N, et al. Thyroid hormones in children on antiepileptic therapy. Int J Neurosci 2012;122(2):69-73
   PubMed Web of Science ®Google Scholar
• Turan MI, Cayir A, Ozden O, Tan H. An examination of the mutual effects of valproic acid, carbamazepine, and phenobarbital on 25-hydroxyvitamin D levels and thyroid function tests. Neuropediatrics 2014;45(1):16-21
   PubMed Web of Science ®Google Scholar
• Kafadar İ, Kılıç BA, Arapoglu M, et al. Evaluation of thyroid hormones in children receiving carbamazepine or valproate: a prospective study. J Child Neurol 2015;30(1):63-8
   PubMed Web of Science ®Google Scholar
• Vainionpää LK, Mikkonen K, Rättyä J, et al. Thyroid function in girls with epilepsy with carbamazepine, oxcarbazepine, or valproate monotherapy and after withdrawal of medication. Epilepsia 2004;45(3):197-203
   PubMed Web of Science ®Google Scholar
• Attilakos A, Katsarou E, Prassouli A, et al. Thyroid function in children with epilepsy treated with sodium valproate monotherapy: a prospective study. Clin Neuropharmacol 2009;32(1):32-4
   PubMed Web of Science ®Google Scholar
• Lossius MI, Taubøll E, Mowinckel P, Gjerstad L. Reversible effects of antiepileptic drugs on thyroid hormones in men and women with epilepsy: a prospective randomized double-blind withdrawal study. Epilepsy Behav 2009;16(1):64-8
   PubMed Web of Science ®Google Scholar
• De Luca F, Arrigo T, Pandullo E, et al. Changes in thyroid function tests induced by 2 month carbamazepine treatment in L-thyroxine-substituted hypothyroid children. Eur J Pediatr 1986;145(1-2):77-9
   PubMed Web of Science ®Google Scholar
• Hamed SA. Atherosclerosis in epilepsy: Its causes and implications. Epilepsy Behav 2014;41:290-6
   PubMed Web of Science ®Google Scholar
• de Chadarevian JP, Legido A, Miles DK, Katsetos CD. Epilepsy, atherosclerosis, myocardial infarction, and carbamazepine. J Child Neurol 2003;18:150-1
   PubMed Web of Science ®Google Scholar
• Sankhyan N, Gulati S, Hari S, et al. Noninvasive screening for preclinical atherosclerosis in children on phenytoin or carbamazepine monotherapy: A cross sectional study. Epilepsy Res 2013;107:121-6
   PubMed Web of Science ®Google Scholar
• Lhatoo SD, Johnson AL, Goodridge DM, et al. Mortality in epilepsy in the first 11 to 14 years after diagnosis: multivariate analysis of a long-term, prospective, population-based cohort. Ann Neurol 2001;49:336-44
   PubMed Web of Science ®Google Scholar
• Hsieh CY, Lai EC, Yang YH, Lin SJ. Comparative stroke risk of antiepileptic drugs in patients with epilepsy. Epilepsia 2013;54:172-80
   PubMed Web of Science ®Google Scholar
• Mintzer S, Skidmore CT, Abidin CJ, et al. Effects of antiepileptic drugs on lipids, homocysteine, and C reactive protein. Ann Neurol 2009;65:448-56
   PubMed Web of Science ®Google Scholar
• Betteridge T, Fink J. Phenytoin toxicity and thyroid dysfunction. N Z Med J 2009;122(1303):102-4
   PubMedGoogle Scholar
• Boron WF, Boulpaep E. Chapter 48: “synthesis of thyroid hormones”. Medical Physiology: A Cellular And Molecular Approaoch. Elsevier/Saunders, United Kingdom; 2003. p. 1300
   Google Scholar
• Warner MH, Beckett GJ. Mechanisms behind the non-thyroidal illness syndrome: an update. J Endocrinol 2010;205(1):1-13
   PubMed Web of Science ®Google Scholar
• Gharib H, Tuttle RM, Baskin HJ, et al. Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. Endocr Pract 2004;10(6):497-501
   PubMedGoogle Scholar
• Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med 2000;160(4):526-34
   PubMed Web of Science ®Google Scholar
• Pop VJ, Brouwers EP, Vader HL, et al. Maternal hypothyroxineaemia during early pregnancy and subsequent child development: a 3-year follow-up study. Clin Endocrinol (Oxf) 2003;59(3):282-8
   PubMed Web of Science ®Google Scholar
• Sharma K, Behera JK, Sood S, et al. Study of cognitive functions in newly diagnosed cases of subclinical and clinical hypothyroidism. J Nat Sci Biol Med 2014;5(1):63-6
   Google Scholar
• Cioffi F, Lanni A, Goglia F. Thyroid hormones, mitochondrial bioenergetics and lipid handling. Curr Opin Endocrinol Diabetes Obes 2010;17(5):402-7
   PubMed Web of Science ®Google Scholar
• Yang N, Yao Z, Miao L, et al. Novel clinical evidence of an association between homocysteine and insulin resistance in patients with hypothyroidism or subclinical hypothyroidism. PLoS One 2015;10(5):e0125922
   PubMed Web of Science ®Google Scholar
• Garduño-Garcia Jde J, Alvirde-Garcia U, López-Carrasco G, et al. TSH and free thyroxine concentrations are associated with differing metabolic markers in euthyroid subjects. Eur J Endocrinol 2010;163(2):273-8
   PubMed Web of Science ®Google Scholar
• López Rubio MA, Tárraga López PJ, Rodríguez Montes JA, et al. Subclinical hypothyroidism and cardiovascular risk. Nutr Hosp 2015;31(5):2095-102
   PubMed Web of Science ®Google Scholar
• Danese MD, Ladenson PW, Meinert CL, Powe NR. Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. J Clin Endocrinol Metab 2000;85(9):2993-3001
   PubMed Web of Science ®Google Scholar
• Razvi S, Ingoe L, Keeka G, et al. The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial. J Clin Endocrinol Metab 2007;92(5):1715-23
   PubMed Web of Science ®Google Scholar
• Rodondi N, Bauer DC, Cappola AR, et al. Subclinical thyroid dysfunction, cardiac function, and the risk of heart failure. The Cardiovascular Health study. J Am Coll Cardiol 2008;52(14):1152-9
   PubMed Web of Science ®Google Scholar
• De Groot L, Abalovich M, Alexander EK, et al. Management of thyroid dysfunction during pregnancy and postpartum: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2012;97(8):2543-65
   PubMed Web of Science ®Google Scholar
• Alexander EK, Marqusee E, Lawrence J, et al. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med 2004;351(3):241-9
   PubMed Web of Science ®Google Scholar
• Burtis CA, Ashwood ER, Bruns DE. Tietz textbook of clinical chemistry and molecular diagnostics. 5th edition. Elsevier Saunders, United Kingdom; 1920
   Google Scholar
• Aanderud S, Myking OL, Strandjord RE. The influence of carbamazepine on thyroid hormones and thyroxinee binding globulin in hypothyroid patients substituted with thyroxinee. Clin Endocrinol (Oxf) 1981;15(3):247-52
   PubMed Web of Science ®Google Scholar
• Bentsen KD, Gram L, Veje A. Serum thyroid hormones and blood folic acid during monotherapy with carbamazepine or valproate. A controlled study. Acta Neurol Scand 1983;67(4):235-41
   PubMed Web of Science ®Google Scholar
• Ericsson UB, Bjerre I, Forsgren M, Ivarsson SA. Thyroglobulin and thyroid hormones in patients on long-term treatment with phenytoin, carbamazepine, and valproic acid. Epilepsia 1985;26(6):594-6
   PubMed Web of Science ®Google Scholar
• Verrotti A, Laus M, Scardapane A, et al. Thyroid hormones in children with epilepsy during long-term administration of carbamazepine and valproate. Eur J Endocrinol 2009;160(1):81-6
   PubMed Web of Science ®Google Scholar
• Hirfanoglu T, Serdaroglu A, Camurdan O, et al. Thyroid function and volume in epileptic children using carbamazepine, oxcarbazepine and valproate. Pediatr Int 2007;49(6):822-6
   PubMed Web of Science ®Google Scholar
• Verrotti A, Basciani F, Morresi S, et al. Thyroid hormones in epileptic children receiving carbamazepine and valproic acid. Pediatr Neurol 2001;25(1):43-6
   PubMed Web of Science ®Google Scholar
• Mikati MA, Tarabay H, Khalil A, et al. Risk factors for development of subclinical hypothyroidism during valproic acid therapy. J Pediatr 2007;151(2):178-81
   PubMed Web of Science ®Google Scholar
• Kim SH, Chung HR, Kim SH, et al. Subclinical hypothyroidism during valproic acid therapy in children and adolescents with epilepsy. Neuropediatrics 2012;43(3):135-9
   PubMed Web of Science ®Google Scholar
• Doneray H, Kara IS, Karakoc A, et al. Serum thyroid hormone profile and trace elements in children receiving valproic acid therapy: a longitudinal and controlled study. J Trace Elem Med Biol 2012;26(4):243-7
   PubMed Web of Science ®Google Scholar
• Isojärvi JI, Turkka J, Pakarinen AJ, et al. Thyroid function in men taking carbamazepine, oxcarbazepine, or valproate for epilepsy. Epilepsia 2001;42(7):930-4
   PubMed Web of Science ®Google Scholar
• Garoufi A, Koemtzidou E, Katsarou E, et al. Lipid profile and thyroid hormone concentrations in children with epilepsy treated with oxcarbazepine monotherapy: a prospective long-term study. Eur J Neurol 2014;21(1):118-23
   PubMed Web of Science ®Google Scholar
• Isojärvi JI, Airaksinen KE, Mustonen JN, et al. Thyroid and myocardial function after replacement of carbamazepine by oxcarbazepine. Epilepsia 1995;36(8):810-16
   PubMed Web of Science ®Google Scholar
• Goldberg-Stern H, Yaacobi E, Phillip M, de Vries L. Endocrine effects of valproic acid therapy in girls with epilepsy: A prospective study. Eur J Paediatr Neurol 2014;18(6):759-65
   PubMed Web of Science ®Google Scholar
• Garoufi A, Koemtzidou E, Katsarou E, et al. Lipid profile and thyroid hormone concentrations in children with epilepsy treated with oxcarbazepine monotherapy: a prospective long-term study. Eur J Neurol 2014;21(1):118-23
   PubMed Web of Science ®Google Scholar
• Sahu JK, Gulati S, Kabra M, et al. Evaluation of subclinical hypothyroidism in ambulatory children with controlled epilepsy on valproate monotherapy. J Child Neurol 2012;27(5):594-7
   PubMed Web of Science ®Google Scholar
• Hamed SA, Radwan MEN, Haridi MA, Hassan MM. Thyroid Gland Volume in Adults with Epilepsy: Relationship to Thyroid hormonal function. J Neurol Neurosci 2014;5(3):2
   Google Scholar
• Hegedüs L, Hansen JM, Lühdorf K, et al. Increased frequency of goiter in epileptic patients on long-term phenytoin or carbamazepine treatment. Clin Endocrinol (Oxf) 1985;23(4):423-9
   PubMed Web of Science ®Google Scholar
• Chakova L, Karakhanian E, Dimitrov H, Lutakova E. Effect of antiepileptic drugs on the thyroid gland in children with epilepsy (preliminary report). Folia Med (Plovdiv) 1998;40(1):80-3
   PubMedGoogle Scholar
• Luoma PV, Myllyla VV, Sotaniemi EA, et al. Plasma high-density lipoprotein cholesterol in patients with epilepsy treated with various anticonvulsants. Eur Neurol 1980;19(1):67-72
   PubMed Web of Science ®Google Scholar
• Larkin JG, McKee PJ, Forrest G, et al. Lack of enzyme induction with oxcarbazepine (600 mg daily) in healthy subjects. Br J Clin Pharmacol 1991;31(1):65-71
   PubMed Web of Science ®Google Scholar
• Klosterskov Jensen P, Saano V, Haring P, et al. Possible interaction between oxcarbazepine and an oral contraceptive. Epilepsia 1992;33(6):1149-52
   PubMed Web of Science ®Google Scholar
• Benedetti MS, Whomsley R, Baltes E, Tonner F. Alteration of thyroid hormone homeostasis by antiepileptic drugs in humans: involvement of glucuronosyltransferase induction. Eur J Clin Pharmacol 2005;61(12):863-72
   PubMed Web of Science ®Google Scholar
• Fichsel H, Knöpfle G. The effect of primidone treatment of thyroid hormones in epileptic children and adolescents (author’s transl). Monatsschr Kinderheilkd 1977;125(8):791-6
   PubMed Web of Science ®Google Scholar
• Joffe RT, Gold PW, Uhde TW, Post RM. The effects of carbamazepine on the thyrotropin response to thyrotropin-releasing hormone. Psychiatry Res 1984;12(2):161-6
   PubMed Web of Science ®Google Scholar
• Bongu D, Sachdev J, Kabadi UM. Effects of carbamazepine on the hypothalamic-pituitary-thyroid axis. Endocr Pract 1999;5(5):239-44
   PubMedGoogle Scholar
• Miller J, Carney P. Central hypothyroidism with oxcarbazepine therapy. Pediatr Neurol 2006;34(3):242-4
   PubMed Web of Science ®Google Scholar
• Brown R, Imran SA, Ur E, Wilkinson M. Valproic acid and CEBPalpha-mediated regulation of adipokine gene expression in hypothalamic neurons and 3T3-L1 adipocytes. Neuroendocrinol 2008;88(1):25-34
   PubMed Web of Science ®Google Scholar
• Simko J, Horacek J. Carbamazepine and risk of hypothyroidism: a prospective study. Acta Neurol Scand 2007;116(5):317-21
   PubMed Web of Science ®Google Scholar
• Ladenson PW, Singer PA, Ain KB, et al. American Thyroid Association guidelines for detection of thyroid dysfunction. Arch Intern Med 2000;160(11):1573-5
   PubMed Web of Science ®Google Scholar
• Chopra IJ, Van Herle AJ, Teco GN, Nguyen AH. Serum free thyroxine in thyroidal and nonthyroidal illnesses: a comparison of measurements by radioimmunoassay, equilibrium dialysis, and free thyroxine index. J Clin Endocrinol Metab 1980;51(1):135-43
   PubMed Web of Science ®Google Scholar
• Apeland T, Kristensen O, Strandjord RE, Mansoor MA. Thyroid function during B-vitamin supplementation of patients on antiepileptic drugs. Clin Biochem 2006;39(3):282-6
   PubMed Web of Science ®Google Scholar
• Seligmann H, Potasman I, Weller B, et al. Phenytoin-folic acid interaction: a lesson to be learned. Clin Neuropharmacol 1999;22(5):268-72
   PubMed Web of Science ®Google Scholar
• Paragliola RM, Prete A, Kaplan PW, et al. Treatment of hypopituitarism in patients receiving antiepileptic drugs. Lancet Diabetes Endocrinol 2015;3(2):132-40
   PubMed Web of Science ®Google Scholar